News on Novo Nordisk

Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more

GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today

Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad

Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump

Going Into Earnings: Is Novo Nordisk Stock a Buy, a Sell or Fairly Valued?

LVMH overtakes Novo Nordisk as Europe's most valuable company

London's FTSE 100 closes at record high; Novo Nordisk slides after U.S. lists its drugs for price talks

Ozempic could get cheaper as Medicare eyes drug price negotiations -- and Novo Nordisk stock slips

European Growth Segment Hit by Novo Nordisk Decline

European markets close higher ahead of Christmas shutdown; Novo Nordisk resumes recovery

Novo Nordisk: Shares Look Fairly Valued After CagriSema Disappointment - Clone

Novo Nordisk shares tumble as data on weight-loss drug trial disappoints

Stocks making the biggest moves premarket: Novo Nordisk, Honda, Xerox, Tesla and more

Stocks making the biggest moves midday: Novo Nordisk, Mission Produce, Occidental Petroleum and more

Stocks making the biggest moves premarket: Novo Nordisk, FedEx, Nike, Starbucks, MicroStrategy and more

Novo Nordisk shares plunge on the back of disappointing trial results

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps

Ozempic Maker Novo Nordisk's Plunge Echoes Nokia Risk

Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing

Eli Lilly and Novo Nordisk's Obesity Moat Just Got Stronger

A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drug

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Weight loss drug industry injects wealth into Novo Nordisk home country